Skip to main content
. 2022 Jun 8;12(6):1413. doi: 10.3390/diagnostics12061413

Table 1.

Details of patients included in this study.

Groups N
(Total n = 69)
Age (Years)
(Mean/Range)
Healthy control 26 58 (44–85)
Adenoma 20 64 (27–79)
CRC 23 64 (39–81)
Gender Percentage
Female 24 34.8
Male 45 65.2
UICC Stage
1 3 13.1
2 4 17.4
3 7 30.4
4 9 39.1
T-Stage
1 1 4.3
2 3 13.1
3 15 65.2
4 4 17.4
N-Stage
0 8 34.8
1 5 21.7
2 10 43.5
M-Stage
0 14 60.9
1 9 39.1